Ticker Scorecard - SYRE Basics Company: Spyre Therapeutics, Inc. IPO Date: April 4, 2016 Sector: Healthcare Industry: Biotech Market Cap: $1.28B Activated in VL: True Average Daily Range Avg Daily Range: $0.99 | 3.53% Avg Daily Range (30 D): $0.65 | 2.92% Avg Daily Range (90 D): $0.84 | 3.06% Institutional Daily Volume Avg Daily Volume: .41M Avg Daily Volume (30 D): .48M Avg Daily Volume (90 D): .46M Trade Size Avg Trade Size (Sh.): 67 Avg Trade Size (Sh.) (30 D): 62 Avg Trade Size (Sh.) (90 D): 58 Institutional Trades Total Inst.Trades: 599 Avg Inst. Trade: $2.11M Avg Inst. Trade (30 D): $1.56M Avg Inst. Trade (90 D): $1.8M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.87M Avg Closing Trade (30 D): $1.94M Avg Closing Trade (90 D): $2.14M Avg Closing Volume: 104.41K     News Mar 5, 2024 @ 3:56 PM NIO Reports Upbeat Earnings, Joins Dave, V2X, Risk... Source: Avi Kapoor Mar 4, 2024 @ 1:50 PM Here's What Could Help Spyre Therapeutics (SYRE) M... Source: Zacks Equity Research Feb 6, 2024 @ 2:55 PM Here's Why Spyre Therapeutics (SYRE) Could be Grea... Source: Zacks Equity Research Financials   TTM Q2 2024 Q1 2024 Basic EPS $-1.36 $-.86 $-1.2 Diluted EPS $-1.36 $-.86 $-1.2 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -69.03M $ -38.84M $ -43.86M Operating Income / Loss $ -55.39M $ -44.15M $ -47.77M Cost of Revenue $ $ $ Net Cash Flow $ 26.12M $ -182.41M $ 38.66M PE Ratio     Splits Sep 08, 2023:   25:1